All residents are required to participate in a research project and/or quality improvement project each academic year. Our goal is to have each resident present at a regional and national level.
This event is held annually in early June allowing all residents to present their research in front of faculty and hospital staff
It is a requirement for each resident to present on a national level by the end of their residency. Our residents have a strong presence at national conferences and have won many awards for their research projects.
Publications are encouraged and many resources are available to guide you through this process. Our project advisors and internal medicine faculty are available and eager to help every step of the way.
Director of Research Development
Dr. Serap Sobnosky is a principal investigator in the AEGIS-III clinical trial and is currently involved in multiple research projects in the area of cardiology and interventional cardiology.
She is dedicated to mentoring residents and guiding them through their research endeavors.
Double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 in subjects with ACS . This is a multi-center study including Johns Hopkins and Harvard which is currently in phase 3, Planned to end 2022.
Care Access COVID Clinical Trial
Select residents who met both internal and external criteria were allowed to participate in a phase 3 clinical research trial which focused on a new coronavirus monoclonal antibody drug during the height of the pandemic. Many of our residents became sub-investigators due to this opportunity and they continue to work in this area of clinical research.
Dr. Christine Thai, faculty in rheumatology is a principal investigator who mentors our residents.